(HEALIO) Early detection, screening and better treatments have led to a 38% reduction in mortality since the late 1980s, resulting in 297,300 fewer breast cancer deaths.
To mark Breast Cancer Awareness Month, Healio Internal Medicine has compiled seven important recent findings in breast cancer research.
Women lack information on the harms of breast cancer screening.
Women are likely to know of the benefits of mammography, but not the potential harms, indicating that they lack balanced information from physicians and public health officials.
Mammography is associated with overdiagnosis of breast cancer.
Breast cancer screening resulted in a substantial overdiagnosis in Denmark, with approximately one in three women being treated unnecessarily.
Hormonal contraceptives do not increase recurrence of breast cancer or mortality.
Breast cancer survivors who used hormonal contraception did not have an increased risk for recurrence or mortality compared with those who did not.
Opioid use in breast cancer patients is linked to treatment nonadherence.
Breast cancer patients who use opioids to manage their pain are significantly less likely to adhere to vital therapies and are at a significantly increased risk for death.
Low-dose aspirin may reduce breast cancer risk.
Women with type 2 diabetes who are taking low-dose aspirin had a lower occurrence of breast cancer than those not taking aspirin.
Point-of-care screening outperforms other screening methods.
Health care providers who use point-of-care breast cancer screening referred more patients, and had more patients get mammograms, than providers who referred only at preventive care visits.
Primary care providers can help you navigate screening guidelines and prevent breast cancer.
Breast cancer is the most common cancer in women, affecting approximately 123 out of every 1,000 women, and is the second leading cause of cancer death among women.